CUSIP: 91324P102
Q1 2026 13F Holders as of 31 Mar 2026
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,584,527
-
Share change
-
0
-
Total reported value
-
$2,490,189,019
-
Put/Call ratio
-
113%
-
Price per share
-
$270.59
-
Number of holders
-
161
Security key
91324P102
Report period
Q1 2026
Institutions
161
Top holders
10
Reporting periods
Holder history for CUSIP 91324P102
Recent filing periods:
Top shareholders of 91324P102 - UNITEDHEALTH GROUP INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of UNITEDHEALTH GROUP INC - COM as of Q1 2026
As of 31 Mar 2026,
UNITEDHEALTH GROUP INC - COM was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,584,527 shares.
The largest 10 holders included
ENVESTNET ASSET MANAGEMENT INC, PRINCIPAL FINANCIAL GROUP INC, PineStone Asset Management Inc., ROYAL LONDON ASSET MANAGEMENT LTD, Mirae Asset Global Investments Co., Ltd., FIFTH THIRD BANCORP, Thrivent Financial for Lutherans, COOKE & BIELER LP, MFF Capital Investments Ltd, and Vantage Investment Partners, LLC.
This page lists
161
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q1 2026 vs Q4 2025 Across Filers
| Investor |
Q4 2025 Shares |
Q1 2026 Shares |
Share Diff |
Share Chg % |
Q4 2025 Value $ |
Q1 2026 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.